Search Within

Population Sciences Research Program

  1. "Kenneth Offit"
  2. "Gerstner Sloan Kettering Graduate School of Biomedical Sciences"
  3. "Semanti Mukherjee"
  4. "Vijai Joseph"
  5. "Michael Walsh"
  6. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Alumni (GSK) (7)
  2. Center for Pancreatic Cancer Research (7)
  3. Clinical Genetics Service (7)
  4. Department of Medicine (7)
  5. Epidemiology and Biostatistics (7)
  6. GSK Faculty (7)

More Groups

People
  1. Diana Mandelker (7)
  2. Kenneth Offit (7)
  3. Maria Carlo (7)
  4. Michael Walsh (7)
  5. Semanti Mukherjee (7)
  6. Vijai Joseph (7)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (1)
  5. 2018 (1)
Publications
  1. Cancer Epidemiology Biomarkers and Prevention (2)
  2. Journal of Clinical Oncology (2)
  3. JAMA Oncology (1)
  4. Nature Cancer (1)
  5. Nature Genetics (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. American Medical Association (1)
  4. Nature Publishing Group (1)
  5. Nature Research (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition
    Meeting Abstract

    Walsh, M. F.; Mukherjee, S.; Gao, M.; Fiala, E.; Mauguen, A.; Kemel, Y.; Bandlamudi, C.; Mehine, M.; Carlo, M. I.; Murciano-Goroff, Y. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Multiple primary cancers in patients undergoing tumor-normal sequencing define novel associations
    Journal Article

    Liu, Y. L.; Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Tkachuk, K.; Kemel, Y.; Maio, A.; Belhadj, S.; Carlo, M. I.; Latham, A.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • The context-specific role of germline pathogenicity in tumorigenesis
    Journal Article

    Srinivasan, P.; Bandlamudi, C.; Jonsson, P.; Kemel, Y.; Chavan, S. S.; Richards, A. L.; Penson, A. V.; Bielski, C. M.; Fong, C.; Syed, A.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Characterization of patients with multiple primary tumors
    Meeting Abstract

    Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Kemel, Y.; Tkachuk, K.; Liu, Y. L.; Carlo, M. I.; Walsh, M. F.; Latham, A.; Dubard-Gault, M. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save